Collectively, these findings establish the KLF10/GPX4 axis as a previously unrecognized regulator of diabetes-associated vascular ferroptosis and suggest that PTX may offer a promising therapeutic approach for limiting ferroptosis-driven vascular injury in diabetes. Here, KLF10 is linked to diabetes mellitus.